在雷达下飞行:在Staphylococcus epidermidis腹膜炎中,万科米辛异阻力与治疗失败有关
Malgorzata K Kopczyk1,2, Joshua P Ramsay3, Kieran T Mulroney1,2
1UWA Center for Medical Research (affiliated with the Harry Perkins Institute of Medical Research), The University of Western Australia, Perth, Australia.
ASM case reports
|November 17, 2025
概括
抗微生物耐药性 (AMR) 可以通过标准测试错过. 一例Staphylococcus epidermidis 周炎病例显示出万科米辛异阻力,导致治疗失败并突出诊断局限性.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 一个健康,一个健康.
背景情况:
- 抗菌素耐药性 (AMR) 在全球范围内对人类和动物健康构成重大威胁.
- 传统的抗微生物敏感性测试 (AST) 可能无法检测出所有形式的抗菌素耐药性,包括异性抗药性.
- 异种耐药性可能导致治疗失败,即使孤立的细胞似乎对抗生素敏感.
研究的目的:
- 报告患有 Staphylococcus epidermidis 周周炎的患者的万科米辛治疗失败的情况.
- 调查S. epidermidis分离物中存在万科米辛异能耐药性的存在.
- 突出目前用于检测AMR的诊断方法的局限性.
主要方法:
- 一个患有腹膜透析 (PD) 相关腹膜炎的患者的病例介绍.
- 使用了传统的AST (VITEK 2和微稀释) 和人口分析概况 (PAP-AUC).
- 全基因组测序 (WGS) 在S. epidermidis分离物上进行.
主要成果:
- 从万科米辛治疗失败病例中分离出的S. epidermidis被始终错误地归类为常规AST对万科米辛敏感.
- PAP-AUC证实了隔离物中的万科米辛异体电阻.
- WGS没有识别出与万科米辛耐药性相关的已知遗传突变.
结论:
- 传统的AST和WGS未能在这种S. epidermidis周周炎病例中检测到万科米辛异阻力.
- 这凸显了诊断和管理AMR的挑战,特别是异阻力.
- 需要进一步的研究来改进对神秘的AMR形式的诊断方法,以提高患者的治疗结果.
相关概念视频
Development of Antibiotic Resistance
1.2K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.2K
Antibiotic Selection
59.3K
Overview
59.3K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.1K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.1K
Antimicrobial Effectiveness
889
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
889
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K


